Scientists extracted asperigimycins from Aspergillus flavus, a fungus, showing potential against leukemia cells. Bioengineered fungal RiPPs disrupt cancer cell division with high specificity, equalling FDA drugs.
Using animal models, he, Dempsey, and the rest of their research team found that H3K36 methylation -- a biochemical process that occurs within the H3 histone protein -- is responsible for turning that plastic state on and off.
The University of Melbourne's Catarina Gago da Graça, PhD Candidate at the Doherty Institute, said the research highlights how ID3+ T cells hold the key to overcoming one of the biggest challenges in treating chronic diseases -- immune exhaustion.
Nov. 17, 2023 Researchers have identified a protein key to the development of a type of brain cell believed to play a role in disorders like Alzheimer's and Parkinson's diseases and used the discovery to grow the ...
A research team from Kyushu University in Japan has recently discovered a calcium-based mechanism that plays a key role in the disposal of dead cells, shedding light on how our bodies protect themselves from injury and disease.
To make it a bit more challenging, we also added some trick questions, with two people of the same gender: "Jennifer Aniston and Kamala Harris walked into a bar.
Guerreiro tells: "Uncovering the mechanism behind the unusual nuclear organization that characterizes the early embryo has the potential to improve regenerative medicine strategies and human in vitro fertilization outcomes."
Bowel cancer cells have the ability to regulate their growth using a genetic on-off switch to maximize their chances of survival, a phenomenon that's been observed for the first time by researchers at UCL and University Medical Center Utrecht.
"In our previous study, we found small indications that the type of breast cancer might affect the effects of exercise on white blood cells, which is why we wanted to examine it further.
The scalable synthesis of withanolides means that scientists can now produce these compounds in larger amounts, facilitating new research and accelerating the development of withanolide-based cancer treatments.
The new guidance, which will be implemented across every hospital and research institute in Europe that works with patients with bone cancer, are ultimately aimed at moving treatment away from untargeted chemotherapy and more towards precision medicine.
